2,3-Dihydroxypropyl oleate is a lipid of Glycerolipids (GL) class. The involved functions are known as enzyme activity and acyltransferase activity. 2,3-dihydroxypropyl oleate often locates in soluble fraction.
To understand associated biological information of 2,3-Dihydroxypropyl oleate, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
There are no associated biomedical information in the current reference collection.
We collected disease MeSH terms mapped to the references associated with 2,3-Dihydroxypropyl oleate
| MeSH term | MeSH ID | Detail |
|---|---|---|
| Burns | D002056 | 34 associated lipids |
| Body Weight | D001835 | 333 associated lipids |
| Edema | D004487 | 152 associated lipids |
| Arthritis | D001168 | 41 associated lipids |
| Abscess | D000038 | 13 associated lipids |
| Psoriasis | D011565 | 47 associated lipids |
| Hypertension, Renovascular | D006978 | 10 associated lipids |
| Blood Loss, Surgical | D016063 | 6 associated lipids |
There are no associated biomedical information in the current reference collection.
Associated locations are in red color. Not associated locations are in black.
| Location | Cross reference | Weighted score | Related literatures |
|---|
| Function | Cross reference | Weighted score | Related literatures |
|---|
There are no associated biomedical information in the current reference collection.
There are no associated biomedical information in the current reference collection.
There are no associated biomedical information in the current reference collection.
| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Rossetti FC et al. | Optimization of protoporphyrin IX skin delivery for topical photodynamic therapy: Nanodispersions of liquid-crystalline phase as nanocarriers. | 2016 | Eur J Pharm Sci | pmid:26657201 |
| Patil SS et al. | Fabrication of novel GMO/Eudragit E100 nanostructures for enhancing oral bioavailability of carvedilol. | 2016 | Drug Dev Ind Pharm | pmid:26651381 |
| Kolev V et al. | Unit cell structure of water-filled monoolein in inverted hexagonal mesophase in the presence of incorporated tricaprylin and entrapped lysozyme. | 2016 | Eur. Biophys. J. | pmid:26424533 |
| Lopes I et al. | Monoolein-based nanocarriers for enhanced folate receptor-mediated RNA delivery to cancer cells. | 2016 | J Liposome Res | pmid:26340109 |
| Yu X et al. | Melanoma therapy with transdermal mitoxantrone cubic phases. | 2016 | Drug Deliv | pmid:25835224 |
| Sintov AC | Transdermal delivery of curcumin via microemulsion. | 2015 | Int J Pharm | pmid:25655717 |
| Tisor O et al. | Adaptability of monoglyceride-induced crystallization of K2SO4: effect of various anions and lipid chain splay. | 2015 | Langmuir | pmid:25645981 |
| Zhang Y et al. | Transdermal baicalin delivery using diethylene glycol monoethyl ether-mediated cubic phase gel. | 2015 | Int J Pharm | pmid:25543112 |
| Montis C et al. | Magnetocubosomes for the delivery and controlled release of therapeutics. | 2015 | J Colloid Interface Sci | pmid:25533536 |
| Sallam AS et al. | Effect of ethylcellulose and propylene glycol on the controlled-release performance of glyceryl monooleate-mertronidazole periodontal gel. | 2015 | Pharm Dev Technol | pmid:24262092 |